PL

Pablo Lubroth

Founder of Decoding Bio

New York, New York

Overview 

Pablo Lubroth is an Investor at Hummingbird Ventures in New York City, specializing in biotechnology investments across various sectors and stages, including Series B, Pre-seed, and Seed rounds. With a background in research and co-founding ventures like Decoding Bio and Hera Biotech, he has successfully invested in companies like Waypoint Bio and Enveda Biosciences, contributing to the growth of innovative biotech startups.

Work Experience 

  • General Partner

    2025 - Current

    Building and investing across the applied sciences

  • Co-Founder & Editor

    2022

    Your missing guide to breakthrough biotech

Decoding Bio mission is to translate technical developments and trends into an easy-to-read format.

  • Investor

    2020 - 2024

    Built and led the life science practice

  • Investor

    2018 - 2020

    Biotechnology incubations

  • Corporate Development

    2018 - 2018

    BD&L and M&A: gene editing technologies

Welcome to SAGE® Labs, your source for unique, next-generation animal research models featuring specific gene deletions

  • Research

    2015 - 2015

    Neurobiological roots of drug addiction and obsessive-compulsive spectrum disorders at the Belin Lab

  • Research

    2014 - 2014

    Novel drug targets for diabetes

Articles About Pablo

Relevant Websites